Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesotheliomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02153229
What this trial is testing

Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma

Who this might be right for
Epitheliod Malignant Pleural Mesothelioma
Abramson Cancer Center at Penn Medicine 52
Early research (Phase 1)Not Yet RecruitingNCT06652529
What this trial is testing

Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors (Phase 1)MesotheliomaColorectal Carcinoma+2 more
Aromics Therapeutics 35
Early research (Phase 1)Study completedNCT04040231
What this trial is testing

Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma

Who this might be right for
MesotheliomaPleural MesotheliomaWilms Tumor
Memorial Sloan Kettering Cancer Center 10
Not applicableLooking for participantsNCT06037941
What this trial is testing

Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center 20
Large-scale testing (Phase 3)Study completedNCT03762018
What this trial is testing

BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma Malignant Advanced
ETOP IBCSG Partners Foundation 400
Testing effectiveness (Phase 2)Study completedNCT02610140
What this trial is testing

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma
Bayer 248
Not applicableLooking for participantsNCT07561190
What this trial is testing

Multidimensional Omics Analysis in Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma (MPM)
Azienda USL Reggio Emilia - IRCCS 300
Not applicableUnknownNCT05042557
What this trial is testing

Real World Study of MPM in China

Who this might be right for
Malignant Pleural MesotheliomaDiagnoses DiseaseTreatments+1 more
Chinese Academy of Medical Sciences 500
Large-scale testing (Phase 3)Active Not RecruitingNCT06097728
What this trial is testing

MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

Who this might be right for
Unresectable Pleural Mesothelioma
AstraZeneca 863
Testing effectiveness (Phase 2)UnknownNCT03475953
What this trial is testing

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Who this might be right for
Colorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more
Institut Bergonié 747
Early research (Phase 1)Ended earlyNCT04166734
What this trial is testing

Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Advanced Malignant Pleural Mesothelioma
Royal Marsden NHS Foundation Trust 5
Early research (Phase 1)Study completedNCT02798536
What this trial is testing

Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma

Who this might be right for
Mesothelioma
National Cancer Institute (NCI) 21
Early research (Phase 1)Study completedNCT01212367
What this trial is testing

Intrapleural Gene Transfer for Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Abramson Cancer Center at Penn Medicine 13
Testing effectiveness (Phase 2)Study completedNCT01211275
What this trial is testing

Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
The Netherlands Cancer Institute 32
Not applicableLooking for participantsNCT05628376
What this trial is testing

TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO

Who this might be right for
Lung Cancer, Non-small CellSmall Cell Lung CancerPleural Mesothelioma
University College, London 600
Testing effectiveness (Phase 2)Study completedNCT00087698
What this trial is testing

Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma

Who this might be right for
Pleural Neoplasms
Eli Lilly and Company 77
Testing effectiveness (Phase 2)Ended earlyNCT02062632
What this trial is testing

Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy

Who this might be right for
Esophageal CarcinomaHypopharyngeal CarcinomaLaryngeal Carcinoma+11 more
Mayo Clinic 5
Early research (Phase 1)Study completedNCT02159716
What this trial is testing

CART-meso in Mesothelin Expressing Cancers

Who this might be right for
Metastatic Pancreatic (Ductal) AdenocarcinomaEpithelial Ovarian CancerMalignant Epithelial Pleural Mesothelioma
University of Pennsylvania 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT03907852
What this trial is testing

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesothelioma, MalignantMesothelioma; Pleura+8 more
TCR2 Therapeutics 57
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06603987
What this trial is testing

Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

Who this might be right for
Thoracic Solid Malignant Tumor
Stella Pharma Corporation 30
Next Page